Ledford, J. G., Addison, K. J., Francisco, D., Foster, M. W., Voelker, D. R., Que, L. G., & Kraft, M. (2016). Genetic Variation in Surfactant Protein-A2 Results in Altered Regulation of Eosinophil Activities and Enhanced Eosinophilia in Patients with Asthma. Ann Am Thorac Soc, 13 Suppl 1(Suppl 1), S101. https://doi.org/10.1513/AnnalsATS.201508-520MG

Ledford, Julie G., Kenneth J. Addison, Dave Francisco, Matthew W. Foster, Dennis R. Voelker, Loretta G. Que, and Monica Kraft. “Genetic Variation in Surfactant Protein-A2 Results in Altered Regulation of Eosinophil Activities and Enhanced Eosinophilia in Patients with Asthma.” Ann Am Thorac Soc 13 Suppl 1, no. Suppl 1 (March 2016): S101. https://doi.org/10.1513/AnnalsATS.201508-520MG.

Ledford JG, Addison KJ, Francisco D, Foster MW, Voelker DR, Que LG, et al. Genetic Variation in Surfactant Protein-A2 Results in Altered Regulation of Eosinophil Activities and Enhanced Eosinophilia in Patients with Asthma. Ann Am Thorac Soc. 2016 Mar;13 Suppl 1(Suppl 1):S101.

Ledford, Julie G., et al. “Genetic Variation in Surfactant Protein-A2 Results in Altered Regulation of Eosinophil Activities and Enhanced Eosinophilia in Patients with Asthma.” Ann Am Thorac Soc, vol. 13 Suppl 1, no. Suppl 1, Mar. 2016, p. S101. Pubmed, doi:10.1513/AnnalsATS.201508-520MG.

Ledford JG, Addison KJ, Francisco D, Foster MW, Voelker DR, Que LG, Kraft M. Genetic Variation in Surfactant Protein-A2 Results in Altered Regulation of Eosinophil Activities and Enhanced Eosinophilia in Patients with Asthma. Ann Am Thorac Soc. 2016 Mar;13 Suppl 1(Suppl 1):S101.